Search

everythinglearnresearchcommunity

for

Search:↓

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and may need specific interventions to improve it.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Metabolic syndrome reduces effectiveness of hair loss treatment.

Clinical exams are good for diagnosing some women's hair loss, but lab tests aren't always needed.

An older woman had false beliefs after taking a depression medication, which stopped when she stopped the medication.

Acne vulgaris is a common skin condition that can cause low self-esteem and depression, and early treatment is important to prevent scarring.

Eating high-glycemic and dairy foods can increase hormones that may cause acne and other health issues.

People with acne have more CD4+ immune cells in their skin than healthy people.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Cyproterone acetate is effective for acne but less so for hirsutism and alopecia, with some side effects and quick menstrual cycle recovery after treatment.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Women with PCOS are more likely to suffer from depression, anxiety, and stress.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.